
Lawson E. Whiting
About Lawson E. Whiting
Lawson E. Whiting, 57, has served as President and Chief Executive Officer of Brown‑Forman since 2019 and as a director since 2018, following a 28‑year career at the company spanning strategy, finance, and brand leadership roles . Under his tenure, FY2025 saw reported net sales decline 5%, operating income decline 22%, and diluted EPS decline 14% due largely to divestitures, while the company returned $420M in dividends and reported 14.4% ROIC; Brown‑Forman’s 1‑, 3‑, and 5‑year TSR trailed the S&P 500 Consumer Staples and the broader S&P 500 indices during the period shown in the proxy .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Brown‑Forman | President & Chief Executive Officer | 2019–present | Overall corporate strategy and performance; co‑chairs Brown‑Forman/Brown Family Shareholders Committee . |
| Brown‑Forman | EVP & Chief Operating Officer | 2017–2019 | Oversight of operations and execution . |
| Brown‑Forman | EVP & Chief Brands and Strategy Officer | 2015–2017 | Portfolio strategy and brand leadership . |
| Brown‑Forman | SVP & Chief Brands Officer | 2013–2015 | Global brand stewardship . |
| Brown‑Forman | SVP & Managing Director, Western Europe | 2011–2013 | Regional P&L leadership . |
| Brown‑Forman | VP & Finance Director, Western Europe | 2010–2011 | Regional finance leadership . |
| Brown‑Forman | VP & Finance Director, North America | 2009–2010 | Regional finance leadership . |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| Keurig Dr Pepper Inc. (Nasdaq: KDP) | Director | Apr 2025–present | Public company board service . |
| The Brown‑Forman Foundation | Director | Mar 2019–present | Non‑profit foundation role . |
Fixed Compensation
Multi‑year CEO compensation (SEC Summary Compensation Table):
| Metric (USD) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary (incl. holiday bonus) | $1,250,040 | $1,250,040 | $1,276,083 |
| Stock Awards (PBRSUs, grant‑date fair value) | $2,075,901 | $4,765,947 | $4,624,396 |
| SSAR/Option Awards (grant‑date fair value) | $1,786,508 | $2,216,456 | $2,366,441 |
| Non‑Equity Incentive Plan Compensation (STC + LTC) | $3,387,283 | $3,706,929 | $2,969,623 |
| Change in Pension Value & NQDC Earnings | $1,095,610 | $1,145,802 | $2,024,516 |
| All Other Compensation | $55,920 | $108,986 | $188,485 |
| Total | $9,651,262 | $13,194,160 | $13,449,544 |
CEO perquisites and other compensation detail (FY2025):
- 401(k) match $15,542; company‑provided life insurance $2,496; car/aircraft benefits $154,725 including $120,711 personal aircraft use; other items $15,722 .
- CEO is required to use chartered aircraft for security; personal aircraft allowance up to $125,000 annually approved by the Compensation Committee .
Performance Compensation
Short‑Term Incentive (STC) – FY2025 Design and Outcome
- Structure: 80% company performance (underlying net sales growth, underlying operating income growth; equally weighted), 20% individual performance .
- Company results vs grid: Underlying net sales −2% (below 0% threshold), underlying operating income −3% (threshold); company component paid 7% of target .
- CEO STC: Target $1,650,000; actual $521,400 .
| Metric | Weight | Target | Actual | Payout | Notes |
|---|---|---|---|---|---|
| Underlying Net Sales YoY | 40% | 2% (100%), 7% (200% cap) | −2% | Included in 7% company mix payout | Non‑GAAP per Appendix A . |
| Underlying Operating Income YoY | 40% | 4% (100%), 11% (200% cap) | −3% | Included in 7% company mix payout | Non‑GAAP per Appendix A . |
| Individual Performance | 20% | Committee discretion | Uniform treatment across NEOs given restructuring context | Reflected in CEO actual $521,400 | “Building Better” changes impacted IPOs . |
Long‑Term Incentives (FY2025 Grants; 3‑year performance period FY2025–FY2027)
- Equity mix: 2/3 PBRSUs; 1/3 SSARs .
- PBRSU metrics: 50% 3‑yr TSR vs S&P 500 Consumer Staples; 50% 3‑yr adjusted operating income CAGR vs same index; payout 50%–150%; floor at 50% because no time‑based RSUs .
- SSARs: Become exercisable May 1, 2027; expire Apr 30, 2034; exercise price equals grant‑date close .
| Grant (7/25/2024) | Units/Shares | Terms |
|---|---|---|
| PBRSUs (target) | 109,505 units; grant‑date fair value $4,624,396 | 3‑yr performance; vesting after certification around June 1, 2027 . |
| SSARs (Class B) | 183,445; exercise price $45.07; fair value $2,366,441 | Exercisable 5/1/2027; expire 4/30/2034 . |
Long‑Term Incentive Outcomes (Prior Cycle FY2023–FY2025)
- PBRSU payout: 50% of target based on 3‑yr TSR result at 11th percentile vs S&P 500 Consumer Staples; shares issued 6/2/2025 .
- CEO PBRSUs issued: 13,004 Class A shares for FY2023–FY2025 award .
- Long‑term cash (final cycle; program discontinued thereafter): payout 137%; CEO amount $2,448,223 .
| LTI Outcome | Result |
|---|---|
| PBRSU FY2023–FY2025 | 50% payout; TSR rank 11th percentile vs staples; CEO 13,004 Class A shares issued 6/2/2025 . |
| Long‑Term Cash FY2023–FY2025 | 137% payout; CEO $2,448,223 . |
Equity Ownership & Alignment
Beneficial Ownership (as of April 30, 2025)
| Class | Shares | % of Class |
|---|---|---|
| Class A | 42,501 | <1% |
| Class B | 542,775 | <1% |
- No pledged shares are disclosed for Mr. Whiting; pledge footnotes in the proxy relate to other individuals (e.g., Matias Bentel and W. A. Musselman) .
- Employee stock ownership guidelines: Brown‑Forman has no stock ownership guidelines for employees; the Committee reviews NEO ownership each year when granting stock‑based compensation .
- Hedging/derivatives/short sales are prohibited by policy for officers and directors .
Vested vs. Unvested; Upcoming Vesting/Exercise Windows
| Equity | Status as of 4/30/2025 | Key Dates |
|---|---|---|
| SSARs (older tranches) | Multiple tranches exercisable (e.g., 2016–2021 grants); see Outstanding Awards table . | Various expirations 2026–2031 . |
| SSARs 2022 | 86,430 unexercisable at 4/30/2025 ; became exercisable 5/1/2025 . | Expire 4/30/2032 . |
| SSARs 2023 | 101,906 unexercisable . | Exercisable 5/1/2026; expire 4/30/2033 . |
| SSARs 2024 | 183,445 unexercisable . | Exercisable 5/1/2027; expire 4/30/2034 . |
| PBRSUs FY2024 grant | 62,243 unearned (est. 100% of target shown in table) . | Anticipated vest around June 1, 2026 . |
| PBRSUs FY2025 grant | 109,505 unearned (est. 100% of target shown in table) . | Anticipated vest around June 1, 2027 . |
Insider selling/overhang indicators:
- No SSAR exercises by Mr. Whiting in FY2025; 13,004 Class A shares vested from PBRSUs (2022 grant cycle) in FY2025 .
- 2022 SSARs became exercisable 5/1/2025, creating potential exercise/sale capacity; 2023 and 2024 grants come due 2026 and 2027, respectively .
Employment Terms
- No employment agreements for NEOs; no formal severance plan (consulting agreements may be used for transition) .
- Change‑in‑control: No single‑trigger. On change‑in‑control, options/SSARs vest but follow original schedule; full acceleration and target cash payouts occur only upon qualifying termination within 1 year after a change‑in‑control (double‑trigger) .
- Clawbacks: SEC 10D‑compliant recoupment policy adopted in 2023; additional 2013 recoupment policy may extend lookback to six years for fraud/misconduct .
- Mandatory retirement age: 65 for NEOs and certain executives; Mr. Whiting is 57 .
Potential payments (as if termination occurred 4/30/2025):
| Scenario | Holiday Bonus | STC | LTC | PBRSUs | SSARs | Death Benefit | Total |
|---|---|---|---|---|---|---|---|
| Voluntary Termination (retirement‑eligible) | $21,284 | $521,400 | $2,448,223 | $6,419,453 | – | – | $9,410,360 |
| Involuntary Not for Cause | $21,284 | $521,400 | $2,448,223 | $6,419,453 | – | – | $9,410,360 |
| Death | $21,284 | $1,650,000 | $1,787,024 | $6,826,951 | – | $3,000,000 | $13,285,259 |
| Termination upon Change‑in‑Control (double‑trigger) | $21,284 | $1,650,000 | $1,787,024 | $6,826,951 | – | – | $10,285,259 |
Treatment summaries for retirement, involuntary not for cause, death/disability, and change‑in‑control scenarios (timing, pro‑ration, vesting) are detailed in the proxy .
Board Governance
- Board service: Director since 2018; Management Director (not independent) .
- Committee roles: Executive Committee member (with Chair and Lead Independent Director) .
- Other governance roles: Co‑Chair of the Brown‑Forman/Brown Family Shareholders Committee, facilitating engagement with controlling family stockholders .
- Structure: Chair and CEO roles separated since 2007; Lead Independent Director in place since 2023 to enhance independent oversight .
- Board transitions (2025): Marshall B. Farrer (Brown family) assumed Chair post‑Annual Meeting; Whiting remains CEO/director .
- Attendance/independence context: Board held 5 regular meetings in FY2025; all current directors attended ≥89% of Board/committee meetings; 6 of 11 nominees deemed independent .
- Employee directors (incl. CEO) receive no director fees .
Director compensation benchmarks and guidelines apply to non‑employee directors; 5x annual retainer stock ownership guideline for non‑employee directors (not applicable to Mr. Whiting) .
Compensation Structure Analysis
- Pay mix: High at‑risk compensation (long‑term equity and short‑term incentives), in line with market medians targeted at 50th percentile .
- Metric rigor and outcomes: FY2025 company STC component paid at 7% amid net sales and operating income declines; Committee applied uniform individual performance assessment due to restructuring, resulting in CEO STC of $521,400 vs $1.65M target .
- LTI design evolution: Cash component removed beginning FY2024; equity mix now PBRSUs and SSARs; last cash cycle (FY2023–FY2025) paid at 137% .
- PBRSU floor: 50% payout floor as a design substitute for time‑based RSUs while maintaining performance orientation; FY2023–FY2025 paid at floor due to weak relative TSR .
- Governance safeguards: No single‑trigger CIC; clawbacks; hedging/derivatives prohibited; no repricing/backdating of options/SSARs .
Say‑on‑Pay & Shareholder Feedback
- Last say‑on‑pay (2023): >99% approval; next say‑on‑pay expected at 2026 Annual Meeting .
Compensation Peer Group (Benchmarking)
- 21‑company comparator group spanning consumer staples/beverages and related categories; target pay at 50th percentile .
Performance & Track Record
- FY2025: Reported net sales −5%; operating income −22%; EPS −14% with $420M dividends returned; restructuring charges of $63M to position for growth .
- TSR vs indices: 1‑yr −26%, 3‑yr −19%, 5‑yr −10% vs positive Consumer Staples and S&P 500 benchmarks over same periods; CEO total compensation change trended downward in FY2025 (−8%) aligned with performance .
- 1Q FY2026: Net sales −3% (reported), +1% organic; operating income −7% (reported), +2% organic; outlook reaffirmed .
- Capital allocation: $400M share repurchase authorization (Oct 2025), with CEO commentary signaling confidence in cash generation .
Risk Indicators & Red Flags
- Relative TSR underperformance in PBRSU cycle (11th percentile) led to 50% payout; continued underperformance could weigh on retention if sustained, though PBRSU floor mitigates severity .
- No employee stock ownership guidelines may modestly reduce forced equity alignment, though committee monitors ownership annually .
- Governance mitigants: Double‑trigger CIC; robust clawbacks; hedging/derivatives ban; no option repricing; independent Compensation Committee .
- Leadership transitions: CFO retirement announced for May 1, 2026; search underway—execution risk during transition .
Investment Implications
- Pay‑for‑performance alignment strengthened by low FY2025 STC payout (7% company component) and 50% PBRSU cycle payout; CEO’s FY2025 compensation decreased vs FY2024, signaling downside pay sensitivity to results .
- Near‑term selling pressure appears limited: CEO executed no SSAR exercises in FY2025; however, 2022 SSARs became exercisable on 5/1/2025 and represent optionality if performance and price recover .
- Retention and incentives remain equity‑heavy (PBRSUs/SSARs) with relative metrics vs Consumer Staples, a constructive design if TSR and adjusted operating income relative performance improves .
- Governance structure (separate Chair/CEO; Lead Independent Director; double‑trigger CIC; clawbacks; hedging ban) reduces governance risk; employee directors receive no board pay, aligning compensation primarily with operating performance and equity .
- Execution watch‑items: Delivering organic growth after portfolio pruning and through restructuring (“Building Better”), absorbing CFO transition, and converting repurchase authorization and cost actions into TSR catch‑up relative to staples peers .